Cumberland Pharmaceuticals (CPIX) Net Equity Issued and Repurchased (2018)

Cumberland Pharmaceuticals (CPIX) reported Net Equity Issued and Repurchased of -$909.0 for Q3 2018, down 200.0% sequentially from $909.0 in Q2 2018.

Cumberland Pharmaceuticals (CPIX) Net Equity Issued and Repurchased (2018) Analysis & Trends

Cumberland Pharmaceuticals (CPIX) has 1 years of Net Equity Issued and Repurchased data on file, last reported at -$909.0 in Q3 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	-
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	-
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	-
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	-
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	500,000.00
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	23.60 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	-
10	Cumberland Pharmaceuticals	104.57 Mn	93.23 Mn	7.20 Mn	-

Download Data